Payment Commission Data Act of 2019
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Feb 14, 2019)
Payment Commission Data Act of 2019
This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.
What just happenedFeb 15, 2019
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseFeb 14, 2019
- Feb 15, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 14, 2019Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Feb 14, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Feb 14, 2019IntroReferralH11100
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Feb 14, 2019IntroReferralIntro-H
Introduced in House
- Feb 14, 2019IntroReferral1000
Introduced in House